Zoetis

Zoetis

Yahoo Finance • yesterday

Q2 Rundown: Pfizer (NYSE:PFE) Vs Other Branded Pharmaceuticals Stocks

Q2 Rundown: Pfizer (NYSE:PFE) Vs Other Branded Pharmaceuticals Stocks Let's dig into the relative performance of Pfizer (NYSE:PFE) and its peers as we unravel the now-completed Q2 branded pharmaceuticals earnings season. Looking ahead, t... Full story

Yahoo Finance • 3 days ago

Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?

Zoetis Inc. (NYSE:ZTS) entered 2026 as a leader in animal health, but its latest earnings show that even a strong market position cannot fully insulate the company from weaker consumer demand. Fiscal Q2 2026 revenue remained flat at $2.5 b... Full story

Yahoo Finance • 5 days ago

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

3 of Wall Street's Favorite Stocks We're Skeptical Of The stocks in this article have caught Wall Street's attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of sa... Full story

Yahoo Finance • 6 days ago

Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)

Reflecting On Branded Pharmaceuticals Stocks' Q2 Earnings: Corcept (NASDAQ:CORT) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Corcept (NASDAQ:CORT) and its... Full story

Yahoo Finance • 8 days ago

Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy?

Zoetis (NYSE:ZTS) is an animal health company. Michael Burry is long the stock, several media outlets reported, citing his Substack disclosures. The stock is down about 40% so far this year. Let's break down whether it's worth buying. Why... Full story

Yahoo Finance • 11 days ago

2 Large-Cap Stocks for Long-Term Investors and 1 We Avoid

2 Large-Cap Stocks for Long-Term Investors and 1 We Avoid Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much h... Full story

Yahoo Finance • 12 days ago

Zoetis (ZTS) Remains a Leader, So Why Was It Sold?

Polen Capital Management Llc released its "Polen Focus Growth Strategy" Q2 2026 investor letter. A copy of the letter can be downloaded here. Polen Focus Growth returned 6.33% (net of fees) in the second quarter of 2026, significantly unde... Full story

Yahoo Finance • 13 days ago

Michael Burry Sends Fresh AI Warning on Nebius, Micron and Oracle

This article first appeared on GuruFocus. Michael Burry (Trades, Portfolio) has increased bearish positions tied to artificial intelligence and semiconductor stocks, while adding to selected long holdings, according to a Wednesday Substac... Full story

Yahoo Finance • 13 days ago

Zoetis (ZTS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Steve Frank Chief Executive Officer - Kristin Peck Chief Financial Officer - Wetteny Joseph Full Conf... Full story

Yahoo Finance • 16 days ago

Zoetis (ZTS) Looked Like a Winner. What Went Wrong?

Brown Advisory, an investment management company, released its "Brown Advisory Global Leaders Strategy" for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory's Global Leaders Strategy d... Full story

Yahoo Finance • 16 days ago

US Stock Market Today: S&P 500 Futures Climb On Softer Jobs Data And Yields

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Monday, Aug, 10 2026 US stock futures are pointing hi... Full story

Yahoo Finance • 17 days ago

Zoetis Q2 Earnings Call Highlights

Key Points Interested in Zoetis Inc.? Here are five stocks we like better. Zoetis reported mixed second-quarter results: Revenue was $2.5 billion, flat reported and down 1% organically, while adjusted EPS rose 4% to $1.87 due partly to sh... Full story

Yahoo Finance • 18 days ago

Earnings Scorecard: 95% of healthcare firms deliver EPS wins this week

Major healthcare heavyweights, including Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), Merck (MRK [https://seekingalpha.com/symbol/MRK]), and Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]), reported their quarterly earnings th... Full story

Yahoo Finance • 20 days ago

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

Saccaro's Appointment is Effective August 17, 2026; Wetteny Joseph to Serve as a Special Advisor to the CEO on Financial Matters Until Early 2027 PARSIPPANY, N.J., August 06, 2026--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced... Full story

Yahoo Finance • 23 days ago

Zoetis (ZTS) Growth Weakens Amid Softening Pet Care Demand

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Large Cap Strategy". A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the R... Full story

Yahoo Finance • 28 days ago

Zoetis (ZTS) Slid on Weak Response to Great Ideas

Platinum Asset Management, an investment management company, released its Q2 2026 investor letter for "Platinum International Brands Fund". A copy of the letter can be downloaded here. The fund returned over 4% in the quarter but lost 14%... Full story

Yahoo Finance • 30 days ago

Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says

Elanco Animal Health (ELAN) seems "best-positioned name" into the Q2 print, with IDEXX Laboratories PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • last month

ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff Deadline

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Zoetis (ZTS) To Contact Them Directly To Discuss Their Options If you purchased or acquired Zoetis securities... Full story

Yahoo Finance • last month

Temporary Concerns Present Entry Point in Zoetis (ZTS)

Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for t... Full story

Yahoo Finance • last month

3 Healthcare Stocks with Competitive Advantages

3 Healthcare Stocks with Competitive Advantages From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated... Full story